Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects

J Chang, V P Werth

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.
Original languageEnglish
Title of host publicationExpert Review of Clinical Immunology
Place of PublicationV.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States
Pages1109-1121
Number of pages13
DOIs
Publication statusPublished - 2016

Publication series

NameExpert Review of Clinical Immunology
Volume12

Fingerprint

Cutaneous Lupus Erythematosus
Antimalarials
Smoking Cessation
Therapeutics
Immunosuppressive Agents
Biological Products
PubMed
Vitamin D
Pharmaceutical Preparations
Quality of Life
Databases

Cite this

Chang, J., & Werth, V. P. (2016). Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. In Expert Review of Clinical Immunology (pp. 1109-1121). (Expert Review of Clinical Immunology; Vol. 12). V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States. https://doi.org/10.1080/1744666X.2016.1188006
Chang, J ; Werth, V P. / Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. Expert Review of Clinical Immunology. V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States, 2016. pp. 1109-1121 (Expert Review of Clinical Immunology).
@inbook{5fba0b99a4e149fdbc36a66f4ecbaf16,
title = "Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects",
abstract = "Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.",
author = "J Chang and Werth, {V P}",
year = "2016",
doi = "10.1080/1744666X.2016.1188006",
language = "English",
isbn = "1744-84091744-666X",
series = "Expert Review of Clinical Immunology",
pages = "1109--1121",
booktitle = "Expert Review of Clinical Immunology",

}

Chang, J & Werth, VP 2016, Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. in Expert Review of Clinical Immunology. Expert Review of Clinical Immunology, vol. 12, V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States, pp. 1109-1121. https://doi.org/10.1080/1744666X.2016.1188006

Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. / Chang, J; Werth, V P.

Expert Review of Clinical Immunology. V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States, 2016. p. 1109-1121 (Expert Review of Clinical Immunology; Vol. 12).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects

AU - Chang, J

AU - Werth, V P

PY - 2016

Y1 - 2016

N2 - Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.

AB - Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.

U2 - 10.1080/1744666X.2016.1188006

DO - 10.1080/1744666X.2016.1188006

M3 - Chapter

SN - 1744-84091744-666X

T3 - Expert Review of Clinical Immunology

SP - 1109

EP - 1121

BT - Expert Review of Clinical Immunology

CY - V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States

ER -

Chang J, Werth VP. Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. In Expert Review of Clinical Immunology. V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States. 2016. p. 1109-1121. (Expert Review of Clinical Immunology). https://doi.org/10.1080/1744666X.2016.1188006